CU Medicine has developed a new drug formulation, aTACE, that offers significantly better treatment outcomes for one of the most common types of liver cancer
Headlines
Spotlight
The German native’s firm has been operating in Dongguan for around two decades, evolving from a trading company into an electric motors manufacturer
Watch
trending stories
More Top Stories
Subscribe to The Tea for hot little sips of news every weekday.
China’s smart glasses market is accelerating as shipments double and tech giants invest heavily in AI-powered wearables
